Written and maintained by CASRAI Editorial Board
Last updated
In observational epidemiology, clinical research, and public health methodology, selecting between a cohort study and a case-control study determines the causal inference strength, temporality, rare disease feasibility, and statistical risk metrics (Relative Risk / Risk Ratio vs. Odds Ratio). This guide reviews study design architectures, retrospective vs. prospective cohorts, nested case-control designs, confounding control, and STROBE reporting guidelines.
Study Design Architecture Comparison
| Methodological Parameter | Cohort Study | Case-Control Study |
|---|---|---|
| Starting Participant Stratification | Defined by Exposure Status (Exposed vs. Unexposed cohort). | Defined by Outcome/Disease Status (Cases with disease vs. Controls without disease). |
| Directionality | Forward in time: Exposure → Disease Outcome (Prospective or Historical Retrospective). | Backward in time: Disease Outcome → Historical Exposure Assessment. |
| Primary Measure of Association | Relative Risk (RR) / Incidence Rate Ratio (Direct calculation of absolute incidence rates). | Odds Ratio (OR) (Estimates RR under the rare disease assumption). |
| Optimal Research Utility | Rare exposures, multiple disease outcomes resulting from a single exposure, evaluating incidence. | Rare diseases (e.g., rare cancers), long latency periods, outbreak investigations. |
| Primary Susceptibility to Bias | Loss to follow-up (attrition bias), surveillance bias, high cost and long duration. | Recall bias (differential exposure reporting), control selection bias. |
